elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38762240-7F18169F-F15F-4682-AEA4-250CFAC95434
Q38762240-7F18169F-F15F-4682-AEA4-250CFAC95434
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38762240-7F18169F-F15F-4682-AEA4-250CFAC95434
Late breaking trials of 2015 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.
P2860
Q38762240-7F18169F-F15F-4682-AEA4-250CFAC95434
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38762240-7F18169F-F15F-4682-AEA4-250CFAC95434
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a331eff88191e2daaa7434128deea2c4b8ee9b55
P2860
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.